Organization · Venture Capital
LYZZ CAPITAL
LYZZ Capital is a global venture capital and private equity firm focused on the healthcare sector, particularly in biotech investments. The firm operates with a cross-border strategy, investing in both USD and RMB funds.
Overview
What LYZZ CAPITAL does
What LYZZ CAPITAL is
LYZZ Capital is a global venture capital and private equity firm focused on the healthcare sector, particularly in biotech investments. The firm operates with a cross-border strategy, investing in both USD and RMB funds.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find LYZZ CAPITAL elsewhere
Open the official website or a supported primary organization account.
Capability profile
LYZZ CAPITAL as a funder
Investment thesis
LYZZ Capital invests in talents, assets, and technologies that address unmet medical needs with significant market potential, particularly in China.
Focus narrative
LYZZ Capital primarily invests in the healthcare sector, with a specific emphasis on biotech companies. The firm targets investments that address unmet medical needs and have substantial market potential, particularly in the Chinese market.
Value beyond capital
LYZZ Capital adds value to its portfolio companies through its extensive network in the healthcare sector, deep industry expertise, and a cross-border strategy that facilitates access to both Chinese and global markets. The firm's team leverages their backgrounds in leading pharmaceutical and biotech firms to support portfolio companies in navigating complex market dynamics.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Sectors
- Healthcare · Biotech · Medical Devices · Drug Discovery
- Regions
- Global · Asia · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 38
- Recorded notable exits
- Microtech Medical
Portfolio context
Notable portfolio companies include: Chipscreen Alpha Biopharma Mojiabio Neurelis Wugen MicroTech Zhiyun Yilu Newmed Qpex Biopharma Jumpcode Genomics
Common questions
What to know about LYZZ CAPITAL
Upseed classifies LYZZ CAPITAL under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.